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Screening of Interleukin-2 Production
Inhibitor with Mouse Thymoma EL4 Cells
Sir: Human interleukin-2 (IL-2) regulates many essential immune functions, but its overexpression is causally related to malignancy, autoimmune disease and renal allograft rejection1-3). In order to find immunosuppressants, isotopelabeled enzyme-linked immunosorbent assay (ELISA) and IL-2 reporter gene assay are used to detect IL-2 production, and cyclosporin A (CsA) and FK506 have been found to be powerful IL-2 inhibitors4-6). However, these methods are biohazardous, very costly and nonspecific. Moreover, the long-term treatment (over 24 hours) with test samples is cytotoxic to target T cells. Therefore, we developed a modified method that minimizes this toxic effect by shortening the duration of sample treatment in mouse thymoma EL4, a cytokineproducing T cell line, and also maximizes the amount of test sample applied to the target cells through introduction of a washing step to increase the likelihood of finding a real inhibitor, which might be present at very low concentrations. When culture broth of actinomycetes was pesticidal, and insecticidal activity8,9). However, to the best of our knowledge, the inhibitory potential of piericidin A1
upon IL-2 production in EL4 cells has not been reported until now. In this study, we report for the first time that piericidin A1 inhibits cytokine production in T cells. To isolate piericidin A1 from a Streptomyces sp. MT1882-V (KCTC8800P), we used a series of purification techniques, which included Amberlite XAD-2, EtOAc extraction, silica gel, Sephadex LH-20 and Lobar RP-18 as described previously8-10) Glucopiericidin A, a derivative of piericidin A1, was also purified through similar chromatographic techniques. In each purification step, inhibiting fractions were collected for further purification by TLC on silica gel TLC plates (0.25mm thickness, Merck Co., Germany) developed with a chloroform:MeOH (9:1), and inhibitory activity was tested against PMA-induced IL-2 production in EL4 cells.
To determine the inhibitory pattern of IL-2 production, piericidin A1, glucopiericidin A, staurosporine, CsA, or FK506 was applied to EL4 cells at different concentrations. Fig. 2 shows that FK506 has an IC50 of 15ng/ml for the inhibition of IL-2 production whereas CsA needs a ten times higher concentration (about 150ng/ml) to produce the same level of inhibition, which is consistent with a report that FK506 is 10 to 100 times more potent than cyclosporin A at inhibiting IL-2 mRNA synthesis in Jurkat cells11). However, when EL4 cells were treated with staurosporine, a protein kinase C inhibitor, only cell toxicity was observed without any inhibition of IL-2 production. In Fig. 3 , piericidin. A1, which was isolated as an IL-2 inhibitor, dose-dependently reduced IL-2 production without causing EL4 cell damage, similar to CsA and FK506 (Fig. 2) . Moreover, glucopiericidin A, piericidins derivative, showed no inhibitory activity on IL-2 production in EL4 cells, similar to staurosporine. The present study shows that even as little as 5 mininutes treatment with test samples could be as efficient as longer treatment in finding inhibitors of IL-2 production from many screening sources, and by using this improved method, it is possible to distinguish between a real inhibitor of IL-2 production and cytotoxic compounds, like staurosporine. Thus, other specific compounds affecting IL-2 production can also be selected using this method and subsequently isolated with ease. Additionally, the introduction of a sample washing step after 5 minutes greatly increases the amount of sample applied to target cells, and thus increases the likelihood of selecting an IL-2 inhibitor. IL-2 gene expression is induced via Ca2+- 
